Follicular Lymphoma Video Channel
Explore the latest insights and summaries from experts in Follicular Lymphoma.
Recommended for You
Loading...
Trending Videos This Week
Loading...
Treatment Landscape
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
The Latest Data on New Therapies in FL and MZL
FEATURING
Jordan Carter
- 74 views
- March 6, 2024
Indy Hematology Review
When Not to Watch and Wait: Emerging Strategies in the Treatment of Indolent Lymphoma and MCL
FEATURING
Michael Williams
- 149 views
- April 23, 2024
- 2
SOHO Brazil 2024
FL Updates: Is There a Standard 1L Treatment?
FEATURING
Brad Kahl
- 313 views
- July 11, 2024
- 1
SOHO Brazil 2024
To 2L and Beyond: Treatment Options in R/R MCL
FEATURING
Tycel Phillips
- 34 views
- July 11, 2024
UChicago Medicine
Summary of Bispecific Antibodies for Follicular Lymphoma
FEATURING
David Russler-Germain
- 387 views
- July 29, 2024
- 2
MyCancerHaven
Experts Discuss Current Data on CAR-T in FL
FEATURING
Ravi Vij,
Nausheen Ahmed
- 18 views
- September 5, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment Algorithm for Advanced Stage Follicular Lymphoma
FEATURING
Tayfur Toptas
- 76 views
- September 11, 2024
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
How to Prioritize Therapy for Pts With R/R FL: Choosing Targeted Agents
FEATURING
Joanna Rhodes
- 30 views
- November 12, 2024
Therapeutic Agents
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
The Latest Data on New Therapies in FL and MZL
FEATURING
Jordan Carter
- 74 views
- March 6, 2024
Christopher Flowers
FDA Approval of Zanubrutinib in R/R FL: What You Need to Know
- 519 views
- March 15, 2024
- 1
Bruce D. Cheson
Tazemetostat in R/R FL: Impact of EZH2 Mutational Status on PFS
- 383 views
- May 22, 2024
Northwestern Medicine Oncology and Hematology
EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial
FEATURING
Leo Gordon
- 390 views
- June 28, 2024
- 3
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: PROs After Epcoritamab in R/R Follicular Lymphoma
FEATURING
Wojciech Jurczak
- 34 views
- July 1, 2024
SOHO Brazil 2024
To 2L and Beyond: Treatment Options in R/R MCL
FEATURING
Tycel Phillips
- 34 views
- July 11, 2024
UChicago Medicine
Summary of Bispecific Antibodies for Follicular Lymphoma
FEATURING
David Russler-Germain
- 387 views
- July 29, 2024
- 2
Chaitra Ujjani
Symphony 1 Trial: Tazemetostat Combined With Lenalidomide and Rituximab in R/R FL
- 122 views
- August 13, 2024
Stephen M. Ansell
Tazemetostat Use in Community Settings for Follicular Lymphoma
- 122 views
- August 19, 2024
MyCancerHaven
Experts Discuss Current Data on CAR-T in FL
FEATURING
Ravi Vij,
Nausheen Ahmed
- 18 views
- September 5, 2024
XV Eurasian Hematology-Oncology Congress - EHOC 2024
Treatment Algorithm for Advanced Stage Follicular Lymphoma
FEATURING
Tayfur Toptas
- 76 views
- September 11, 2024
Fred Hutchinson Cancer Center
The Role of CSF1R in Modulating Inflammation and Fibrosis
FEATURING
Rachael Adams
- 45 views
- September 19, 2024
RWJBarnabas Health Rutgers Cancer Institute of New Jersey
How to Prioritize Therapy for Pts With R/R FL: Choosing Targeted Agents
FEATURING
Joanna Rhodes
- 30 views
- November 12, 2024
2024 ASH Annual Meeting Insights Hub
ASH 2024 Insights: Loncastuximab Tesirine and Rituximab in High-Risk R/R Follicular Lymphoma
FEATURING
Juan Alderuccio
- 11 views
- December 17, 2024
Diagnostics & Biomarkers
No available content for Diagnostics & Biomarkers, yet.
Disease Overview
No available content for Disease Overview, yet.
Case Studies
XV Eurasian Hematology-Oncology Congress - EHOC 2024
FL Case Study: Managing Early Relapse
FEATURING
Taner Tan
- 8 views
- September 25, 2024